Abstract
The influence of hepatitis C virus (HCV) infection has been discussed in kidney transplantation. Our case study focused on four points: the clinical course of an HCV-infected recipient; the pathogenesis of hepatic disorders in such a patient; interferon (IFN)-alpha therapy; and the risk of IFN-alpha therapy. A patient was suspected of acquiring HCV via transfusion at kidney transplant. He was examined several times serologically, virologically, endoscopically, and pathologically during a 20-year follow-up. Abnormal biochemical markers were found within a month after transplantation but recovery occurred without any treatment. Within 3 years postoperatively, hepatic disorder developed including peliosis hepatis, nodular regenerative hyperplasia, and cholestasis. These pathological conditions were ascribed to immunosuppressants: cyclophosphamide and azathioprine. Abnormal chemical markers decreased to normal values for 4 consecutive years with the substitution of cyclophosphamide and azathioprine for mizoribine. During the subsequent 13 years, the patient developed chronic hepatitis with clinical and morphological features of hepatitis C infection. Anti-HCV antibody was positive from the second post-transplant year and HCV genome...Continue Reading
References
Jul 11, 1991·The New England Journal of Medicine·P FarciR H Purcell
Nov 7, 1991·The New England Journal of Medicine·R D AachG J Nemo
May 1, 1991·Transplantation·D VisscherR Zarbo
Aug 8, 1985·The New England Journal of Medicine·UNKNOWN Ortho Multicenter Transplant Study Group
Apr 15, 1995·Transplantation·M MagnoneJ P Johnson
Aug 15, 1994·Transplantation·R CavalcantiH Kreis
Jan 1, 1994·Journal of Hepatology·S IzumiY Shinji
Nov 1, 1993·Transplantation·T M ChanI O Ng
Jun 27, 1996·Transplantation·S PolH Kreis
Jan 1, 1994·Transplant International : Official Journal of the European Society for Organ Transplantation·N FujimotoS Nagano
Citations
Nov 13, 2003·Transplantation Proceedings·M A HalimK V Johny
Feb 1, 2000·The American Journal of Medicine·R L Carithers
Feb 20, 2003·Transplantation Proceedings·A K B Jain, J J Fung
Sep 2, 2003·Transplantation Proceedings·H Gäbel
Sep 26, 2001·Infectious Disease Clinics of North America·R Patel
Mar 9, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Thomas Fehr, Patrice M Ambühl
Apr 8, 2011·World Journal of Gastroenterology : WJG·Marek HartlebPiotr Milkiewicz
Apr 5, 2014·PloS One·Fang WeiPeng Hu
May 6, 2014·Gene·Ling-Fei LiMing-Hua Zheng
Mar 15, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Oren ShakedK Rajender Reddy
Nov 4, 2006·Alimentary Pharmacology & Therapeutics·F FabriziP Martin
Jul 19, 2005·Clinics in Liver Disease·Fabrizio FabriziPaul Martin
Sep 12, 1998·Transplantation·T HanafusaS Nagano
May 31, 2001·Journal of Viral Hepatitis·R TeixeiraA K Burroughs
Jun 19, 2018·Transplantation·Mary G BowringChristine M Durand
Oct 30, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nikhil KapilaXaralambos B Zervos
Jun 28, 2003·The International Journal of Artificial Organs·F FabriziP Martin
Dec 2, 2020·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Nicholas JandovitzLewis Teperman